Sort
64,565 grants matching “drug discovery”
Juxta-glomerular cells serve as glomerular epithelial cell progenitors in glomerular disease
$593,267Stuart Shankland · University Of Washington · R01 · FY2022 · DK
Discovery of Antibiotics from Soil Microbiomes Using Metagenomics
$593,250Sean F Brady · Rockefeller University · R35 · FY2023 · GM
CAREER: Molecular Layer Deposition of Porous Organic Frameworks
$593,240Siamak Nejati · University Of Nebraska-Lincoln · · FY2021 · ENG
Cancer Research Training in Molecular Biology
$593,223University Of Virginia Charlottesville · T32 · FY2005 · CA
DAAO Inhibitors for the treatment of Schizophrenia
$593,166Takashi Tsukamoto · Johns Hopkins University · R01 · FY2011 · MH
Risk Prediction for ER Negative Breast Cancer Recurrence
$593,132Melissa L Bondy · Baylor College Of Medicine · R01 · FY2017 · CA
Tumor-targeted inhibitors of stearoyl-CoA desaturase for the treatment of cancer.
$593,022Deepak Nijhawan · Ut Southwestern Medical Center · R01 · FY2018 · CA
Pharmacological neuroprotection in glaucoma
$593,013Washington University · R01 · FY2005 · EY
New Integrative Pathway Analysis Methods to Predict Biomedical Outcomes
$593,005Joshua Michael Stuart · University Of California Santa Cruz · R01 · FY2015 · GM
UAB Center for Clinical and Translational Science (CCTS)
$592,975Kenneth G Saag · University Of Alabama At Birmingham · KL2 · FY2016 · TR
A critical role for macrophage ferroptosis in promoting fungal invasion in lung transplant recipients
$592,966Joe L Hsu · Stanford University · R01 · FY2021 · HL
Photon-counting X-ray and Optical Tomography for Preclinical Cancer Research
$592,947Ge Wang · Rensselaer Polytechnic Institute · R01 · FY2019 · CA
Discovery Approach to Ocular Hypertension
$592,931M. Elizabeth Fini · Tufts Medical Center · R01 · FY2019 · EY
Discovery Approach to Ocular Hypertension
$592,931M. Elizabeth Fini · Tufts Medical Center · R01 · FY2020 · EY
Optimization of S1P3 antagonists for fibrotic disease
$592,901Hugh Rosen · Scripps Research Institute, The · R01 · FY2016 · AR
Optimization of S1P3 antagonists for fibrotic disease
$592,901Hugh Rosen · Scripps Research Institute, The · R01 · FY2017 · AR
Optimization of S1P3 antagonists for fibrotic disease
$592,901Hugh Rosen · Scripps Research Institute, The · R01 · FY2018 · AR
Genomic Studies of the Impact of External Factors on Parasite Development and Disease Outcome
$592,893Joana Carneiro Da Silva · University Of Maryland Baltimore · U19 · FY2022 · AI
Manipulation of the host cell inflammasome by Mycobacterium tuberculosis
$592,882Volker Briken · Univ Of Maryland, College Park · R01 · FY2025 · AI
Engineering ingestible nanosensors for breath-based detection of colorectal cancer
$592,866Leslie Chan · Georgia Institute Of Technology · R37 · FY2025 · CA
Therapeutic targeting of MUC5B in a novel ferret model of idiopathic pulmonary fibrosis
$592,858Steven Mark Rowe · University Of Alabama At Birmingham · U01 · FY2022 · HL
Imaging Hypoxic Pulmonary Vasoconstriction in the Aging Lung with Proton MRI
$592,751Susan R Hopkins · University Of California, San Diego · R01 · FY2016 · HL
Investigating the role of H2A.Z dynamics in regulating cardiac lineage commitment
$592,653Laurie A Boyer · Massachusetts Institute Of Technology · R01 · FY2019 · HL
Motor neuron selector genes and mechanism of their action
$592,617Hynek Wichterle · Columbia University Health Sciences · R56 · FY2017 · NS
Antibiotic Discovery
$592,607Samuel I. Miller · University Of Washington · U54 · FY2008 · AI